12 November 2021>: Articles
Tofacitinib for a Child with Refractory Steroid-Dependent Ulcerative Colitis: A Case Report and Review of the Literature
Unusual or unexpected effect of treatment, Rare disease
Refaa Alajmi E , Munirah Alabdulhadi E , Ali A. Alali E , Mohammad Shehab A*DOI: 10.12659/AJCR.934460
Am J Case Rep 2021; 22:e934460
Figure 1. This graph represents the body mass index (BMI-for-age) based on the World Health Organization method. (A) At the onset of the disease with BMI of 17.3 kg/m2; (B) When she was on infliximab 10 mg/kg every 8 weeks and azathioprine 2.5 mg/kg), her BMI was 19.3 kg/m2. (C) When she relapsed after failing infliximab with BMI of 17.3 kg/m2. (D) The current body mass index BMI is 21.2 kg/m2.